PUBLISHER: Grand View Research | PRODUCT CODE: 1530332
PUBLISHER: Grand View Research | PRODUCT CODE: 1530332
Annuloplasty System Market Size & Trends
The global annuloplasty system market size was estimated at USD 425.2 million in 2023 and is anticipated to grow a CAGR of 5.4% from 2024 to 2030. The increasing prevalence of cardiovascular diseases (CVD) along with the growing geriatric population base, preference for minimally invasive procedures, and heart health awareness programs are some of the major factors driving the market growth. According to the American College of Cardiology, the number of deaths due to CVD has increased from 12.4 million in 1990 to 19.8 million in 2022 globally.
The increasing prevalence of heart valve diseases has led several government and private organizations are take initiatives and conduct programs to spread awareness about heart valve diseases. For instance, in February 2024, the Centre for Valvular Heart Disease (CVHD) hosted a mobile screening program at the University of Ottawa Heart Institute (UOHI) to offer free screening for heart valve and cardiovascular risk factors. Such initiatives by government and private organizations to increase awareness about heart valve diseases and promote diagnosis of these diseases are expected to drive the market growth over the forecast period.
Similarly, the global population is aging, with several countries such as Japan, Italy, and others facing significantly higher risks of an aging population. According to the WHO, the population base aged 60 years or above is expected to more than double to reach 2.1 billion in 2050, increasing from 1 billion in 2020. This population base poses a significant risk of developing cardiovascular diseases over the period. Cardiovascular diseases such as mitral valve regurgitation and tricuspid valve insufficiency may require annuloplasty procedures to restore cardiac function and address valvular defects, which is expected to drive the demand for annuloplasty systems and drive the market growth over the forecast period.
The market players are continuously developing advanced and effective annuloplasty systems to increase the effectiveness and performance of these procedures. Similarly, several companies are developing devices and solutions to increase annuloplasty procedures' success rate. The improved results and successful procedures from these newly developed systems are expected to increase their adoption by various healthcare facilities and drive market growth. For instance, in January 2021, Valcare Medical Ltd. announced its first successful in-human transseptal delivery of the AMEND annuloplasty ring. The AMEND ring is developed to offer clinical standard-surgical treatment with easier procedures. This increasing adoption and success rate of the annuloplasty system is anticipated to increase demand and drive market growth over the forecast period.
Global Annuloplasty System Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and analyzes the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global annuloplasty system market report based on application, end use, and region:
U.S.
Canada
Mexico
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Japan
China
India
Australia
Thailand
South Korea
Brazil
Argentina
South Africa
Saudi Arabia
UAE
Kuwait